Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy
Sign Up to like & getrecommendations! Published in 2022 at "Theranostics"
DOI: 10.7150/thno.68459
Abstract: Rationale: With the advantages of tumor-targeting, pH-responsive drug releasing, and biocompatibility, ferritin nanocage emerges as a promising drug carrier. However, its wide applications were significantly hindered by the low loading efficiency of hydrophobic drugs. Herein,… read more here.
Keywords: tumor; ferritin nanocage; ins fdc; drug ... See more keywords